Biliary elimination of non-steroidal anti-inflammatory drugs in patients

Br J Clin Pharmacol. 1990 Jan;29(1):127-31. doi: 10.1111/j.1365-2125.1990.tb03613.x.

Abstract

In view of evidence in animals that enterohepatic recirculation of non-steroidal anti-inflammatory drugs contributes to small intestinal mucosal damage we have investigated the extent of biliary elimination of three nonsteroidals. Ibuprofen (n = 3), diclofenac (n = 2) and indomethacin (n = 3) were given to six patients with a percutaneous transhepatic cholangiodrainage placed in the bile duct system. One patient received all three drugs. The mean biliary elimination of ibuprofen was 0.82% of the given dose compared with 50.41% urinary excretion. When diclofenac or indomethacin was administered 4.62% and 6.40% of the dose were found in bile, whereas 34.73% and 32.22% (means) were recovered from urine, respectively. The mean percentage eliminated in bile as unchanged drug and active phase II metabolites was 0.15% for ibuprofen, 1.09% for diclofenac and 5.02% for indomethacin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Inflammatory Agents, Non-Steroidal / pharmacokinetics*
  • Bile / metabolism*
  • Cholestasis / metabolism
  • Common Bile Duct Diseases / metabolism
  • Diclofenac / pharmacokinetics
  • Female
  • Humans
  • Ibuprofen / pharmacokinetics
  • Indomethacin / pharmacokinetics
  • Male
  • Middle Aged

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Diclofenac
  • Ibuprofen
  • Indomethacin